Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8<sup>+</sup> T Cells in Breast Cancer Implications for Adoptive Cell Therapy
- DOI
- 10.2174/1389201025666230901094219
- Published
- 2024-10
- Container
- Current Pharmaceutical Biotechnology
- Publisher
- Bentham Science Publishers Ltd.
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2174/1389201025666230901094219,
title = {Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor
CD8<sup>+</sup> T Cells in Breast Cancer Implications for Adoptive Cell Therapy},
author = {Grace Ivonne Gattas Lama and Gregory Noél and Francisco Carlos López Márquez and Faviel Francisco González Galarza and Adria Imelda Prieto Hinojosa and Lydia Enith Nava Rivera and Karen Willard-Gallo and Jesús Rafael Arguëllo Astorga},
year = {2024},
journal = {Current Pharmaceutical Biotechnology},
doi = {10.2174/1389201025666230901094219},
url = {https://doi.org/10.2174/1389201025666230901094219}
}RIS
TY - JOUR TI - Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8<sup>+</sup> T Cells in Breast Cancer Implications for Adoptive Cell Therapy AU - Grace Ivonne Gattas Lama AU - Gregory Noél AU - Francisco Carlos López Márquez AU - Faviel Francisco González Galarza AU - Adria Imelda Prieto Hinojosa AU - Lydia Enith Nava Rivera AU - Karen Willard-Gallo AU - Jesús Rafael Arguëllo Astorga PY - 2024 JO - Current Pharmaceutical Biotechnology DO - 10.2174/1389201025666230901094219 UR - https://doi.org/10.2174/1389201025666230901094219 ER -
APA
Lama, G. I. G., Noél, G., Márquez, F. C. L., Galarza, F. F. G., Hinojosa, A. I. P., Rivera, L. E. N., Willard-Gallo, K., & Astorga, J. R. A. (2024). Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8<sup>+</sup> T Cells in Breast Cancer Implications for Adoptive Cell Therapy. Current Pharmaceutical Biotechnology. https://doi.org/10.2174/1389201025666230901094219
Source records
- crossref · retrieved 2026-09-27T08:14:31.668Z